Stephen Green

AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies

Sonya Zabludoff, Chun Deng, Michael Grondine et al. · Molecular Cancer Therapeutics · 2008 · 407 citations · Full text

Cell Death, Cell Cycle, Cancer Biology +17

AZD1152, a Selective Inhibitor of Aurora B Kinase, Inhibits Human Tumor Xenograft Growth by Inducing Apoptosis

Robert W. Wilkinson, Rajesh Odedra, Simon P. Heaton et al. · Clinical Cancer Research · 2007 · 355 citations · Full text

Sustained Mps1 activity is required in mitosis to recruit O-Mad2 to the Mad1–C-Mad2 core complex

Laura Hewitt, Anthony Tighe, Stefano Santaguida et al. · The Journal of Cell Biology · 2010 · 327 citations · Full text

Discovery, Synthesis, and <i>in Vivo</i> Activity of a New Class of Pyrazoloquinazolines as Selective Inhibitors of Aurora B Kinase

Andrew Mortlock, Kevin M. Foote, Nicola M. Heron et al. · Journal of Medicinal Chemistry · 2007 · 270 citations · Full text

Pharmaceutical Science, Selective Inhibitors, Pharmacotherapy +17

The α₁-Fetoprotein Locus Is Activated by a Nuclear Receptor of the <i>Drosophila</i> FTZ-F1 Family

Luc Galarneau, Jean‐François Paré, Denis Allard et al. · Molecular and Cellular Biology · 1996 · 236 citations · Full text

Genetics, Genomic Mechanism, Molecular Genetics +19